Washington Call to ‘Redouble Efforts’ on SARS-CoV2 Virus Origins Investigation – But Will There be Action at WHA? 27/05/2021 Elaine Ruth Fletcher Amidst fresh calls from US President Joe Biden ordering the science and intelligence community to come up with a more detailed account of how the SARS-CoV2 virus emerged – it’s unclear how much action the World Health Assembly will really see on the issue. Language in the the final-agreed draft of a WHA resolution, Strengthening […] Continue reading -> Israeli – Palestinian Conflict Blocks Full Day At World Health Assembly 26/05/2021 Elaine Ruth Fletcher A longstanding dispute over a perennial World Health Assembly resolution on the health situation in the Israeli-occupied Palestinian territories claimed a full day of WHA delegates’ attention – as countries on both sides of the bitter conflict battled over a draft decision in a prolonged debate, leading up to a painstaking virtual vote by roll […] Continue reading -> Exclusive – United States Holds Back on Bold Move Toward Pandemic Treaty 21/05/2021 Elaine Ruth Fletcher Just days before the World Health Assembly opens, the United States still appears to be stalling on an initiative led by some of its major European allies, to move ahead decisively on proposals for a “Pandemic Treaty”, according to a US draft proposal seen by Health Policy Watch. The Pandemic Treaty proposal to create a […] Continue reading -> The 1 Billion Dose Wager on the IP Waiver 21/05/2021 Elaine Ruth Fletcher & Svĕt Lustig Vijay Rich countries need to cough up 1 billion vaccine doses by September, and big pharma should significantly expand its network of voluntary license sharing and manufacturing – in order to avoid a vote by World Trade Organization members on a controversial proposal to waive all COVID-related intellectual property for the duration of the pandemic. That […] Continue reading -> Far-reaching Proposals For Reform On Table at World Health Assembly – But Will Member States Heed The Call? 20/05/2021 Elaine Ruth Fletcher With an agenda that is more packed than ever – and razor sharp political crises from Gaza to Taiwan to Myanmar also coming to the fore – will the upcoming World Health Assembly prove to be the decisive moment that it should be for global health? Now, more than ever perhaps, huge tensions and inequalities […] Continue reading -> Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Draft ‘Rome Declaration’ by G-20 Global Health Summit – Sidesteps Hard Commitments to New COVID Finance & Vaccine Donations 14/05/2021 Elaine Ruth Fletcher A draft “Rome Declaration” to be issued at next Friday’s G-20’s Global Health Summit, co-hosted by Italy and the European Commission (21 May), makes a series of 10 sweeping commitments to ensure equitable access to vaccines; expand medicines manufacturing capacity; assure WHO access to sites posing an outbreak risk; and invest in global health systems. […] Continue reading -> Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Israeli – Palestinian Conflict Blocks Full Day At World Health Assembly 26/05/2021 Elaine Ruth Fletcher A longstanding dispute over a perennial World Health Assembly resolution on the health situation in the Israeli-occupied Palestinian territories claimed a full day of WHA delegates’ attention – as countries on both sides of the bitter conflict battled over a draft decision in a prolonged debate, leading up to a painstaking virtual vote by roll […] Continue reading -> Exclusive – United States Holds Back on Bold Move Toward Pandemic Treaty 21/05/2021 Elaine Ruth Fletcher Just days before the World Health Assembly opens, the United States still appears to be stalling on an initiative led by some of its major European allies, to move ahead decisively on proposals for a “Pandemic Treaty”, according to a US draft proposal seen by Health Policy Watch. The Pandemic Treaty proposal to create a […] Continue reading -> The 1 Billion Dose Wager on the IP Waiver 21/05/2021 Elaine Ruth Fletcher & Svĕt Lustig Vijay Rich countries need to cough up 1 billion vaccine doses by September, and big pharma should significantly expand its network of voluntary license sharing and manufacturing – in order to avoid a vote by World Trade Organization members on a controversial proposal to waive all COVID-related intellectual property for the duration of the pandemic. That […] Continue reading -> Far-reaching Proposals For Reform On Table at World Health Assembly – But Will Member States Heed The Call? 20/05/2021 Elaine Ruth Fletcher With an agenda that is more packed than ever – and razor sharp political crises from Gaza to Taiwan to Myanmar also coming to the fore – will the upcoming World Health Assembly prove to be the decisive moment that it should be for global health? Now, more than ever perhaps, huge tensions and inequalities […] Continue reading -> Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Draft ‘Rome Declaration’ by G-20 Global Health Summit – Sidesteps Hard Commitments to New COVID Finance & Vaccine Donations 14/05/2021 Elaine Ruth Fletcher A draft “Rome Declaration” to be issued at next Friday’s G-20’s Global Health Summit, co-hosted by Italy and the European Commission (21 May), makes a series of 10 sweeping commitments to ensure equitable access to vaccines; expand medicines manufacturing capacity; assure WHO access to sites posing an outbreak risk; and invest in global health systems. […] Continue reading -> Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Exclusive – United States Holds Back on Bold Move Toward Pandemic Treaty 21/05/2021 Elaine Ruth Fletcher Just days before the World Health Assembly opens, the United States still appears to be stalling on an initiative led by some of its major European allies, to move ahead decisively on proposals for a “Pandemic Treaty”, according to a US draft proposal seen by Health Policy Watch. The Pandemic Treaty proposal to create a […] Continue reading -> The 1 Billion Dose Wager on the IP Waiver 21/05/2021 Elaine Ruth Fletcher & Svĕt Lustig Vijay Rich countries need to cough up 1 billion vaccine doses by September, and big pharma should significantly expand its network of voluntary license sharing and manufacturing – in order to avoid a vote by World Trade Organization members on a controversial proposal to waive all COVID-related intellectual property for the duration of the pandemic. That […] Continue reading -> Far-reaching Proposals For Reform On Table at World Health Assembly – But Will Member States Heed The Call? 20/05/2021 Elaine Ruth Fletcher With an agenda that is more packed than ever – and razor sharp political crises from Gaza to Taiwan to Myanmar also coming to the fore – will the upcoming World Health Assembly prove to be the decisive moment that it should be for global health? Now, more than ever perhaps, huge tensions and inequalities […] Continue reading -> Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Draft ‘Rome Declaration’ by G-20 Global Health Summit – Sidesteps Hard Commitments to New COVID Finance & Vaccine Donations 14/05/2021 Elaine Ruth Fletcher A draft “Rome Declaration” to be issued at next Friday’s G-20’s Global Health Summit, co-hosted by Italy and the European Commission (21 May), makes a series of 10 sweeping commitments to ensure equitable access to vaccines; expand medicines manufacturing capacity; assure WHO access to sites posing an outbreak risk; and invest in global health systems. […] Continue reading -> Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The 1 Billion Dose Wager on the IP Waiver 21/05/2021 Elaine Ruth Fletcher & Svĕt Lustig Vijay Rich countries need to cough up 1 billion vaccine doses by September, and big pharma should significantly expand its network of voluntary license sharing and manufacturing – in order to avoid a vote by World Trade Organization members on a controversial proposal to waive all COVID-related intellectual property for the duration of the pandemic. That […] Continue reading -> Far-reaching Proposals For Reform On Table at World Health Assembly – But Will Member States Heed The Call? 20/05/2021 Elaine Ruth Fletcher With an agenda that is more packed than ever – and razor sharp political crises from Gaza to Taiwan to Myanmar also coming to the fore – will the upcoming World Health Assembly prove to be the decisive moment that it should be for global health? Now, more than ever perhaps, huge tensions and inequalities […] Continue reading -> Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Draft ‘Rome Declaration’ by G-20 Global Health Summit – Sidesteps Hard Commitments to New COVID Finance & Vaccine Donations 14/05/2021 Elaine Ruth Fletcher A draft “Rome Declaration” to be issued at next Friday’s G-20’s Global Health Summit, co-hosted by Italy and the European Commission (21 May), makes a series of 10 sweeping commitments to ensure equitable access to vaccines; expand medicines manufacturing capacity; assure WHO access to sites posing an outbreak risk; and invest in global health systems. […] Continue reading -> Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Far-reaching Proposals For Reform On Table at World Health Assembly – But Will Member States Heed The Call? 20/05/2021 Elaine Ruth Fletcher With an agenda that is more packed than ever – and razor sharp political crises from Gaza to Taiwan to Myanmar also coming to the fore – will the upcoming World Health Assembly prove to be the decisive moment that it should be for global health? Now, more than ever perhaps, huge tensions and inequalities […] Continue reading -> Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Draft ‘Rome Declaration’ by G-20 Global Health Summit – Sidesteps Hard Commitments to New COVID Finance & Vaccine Donations 14/05/2021 Elaine Ruth Fletcher A draft “Rome Declaration” to be issued at next Friday’s G-20’s Global Health Summit, co-hosted by Italy and the European Commission (21 May), makes a series of 10 sweeping commitments to ensure equitable access to vaccines; expand medicines manufacturing capacity; assure WHO access to sites posing an outbreak risk; and invest in global health systems. […] Continue reading -> Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Draft ‘Rome Declaration’ by G-20 Global Health Summit – Sidesteps Hard Commitments to New COVID Finance & Vaccine Donations 14/05/2021 Elaine Ruth Fletcher A draft “Rome Declaration” to be issued at next Friday’s G-20’s Global Health Summit, co-hosted by Italy and the European Commission (21 May), makes a series of 10 sweeping commitments to ensure equitable access to vaccines; expand medicines manufacturing capacity; assure WHO access to sites posing an outbreak risk; and invest in global health systems. […] Continue reading -> Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Draft ‘Rome Declaration’ by G-20 Global Health Summit – Sidesteps Hard Commitments to New COVID Finance & Vaccine Donations 14/05/2021 Elaine Ruth Fletcher A draft “Rome Declaration” to be issued at next Friday’s G-20’s Global Health Summit, co-hosted by Italy and the European Commission (21 May), makes a series of 10 sweeping commitments to ensure equitable access to vaccines; expand medicines manufacturing capacity; assure WHO access to sites posing an outbreak risk; and invest in global health systems. […] Continue reading -> Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts